Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

January 28, 2014; 82 (4) Patient Page

Mild cognitive impairment and progression to dementiaAbout mild cognitive impairment

New findings

John C.S. Breitner
First published January 27, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000158
John C.S. Breitner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Mild cognitive impairment and progression to dementiaAbout mild cognitive impairment
New findings
John C.S. Breitner
Neurology Jan 2014, 82 (4) e34-e35; DOI: 10.1212/WNL.0000000000000158

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
28545

Share

  • Article
  • Info & Disclosures
Loading

WHAT WERE THE MAIN FINDINGS?

Dr. Roberts and colleagues1 examined 2,719 elderly residents of Olmstead County, MN, every 15 months. The examinations showed that 534 persons had mild cognitive impairment, or MCI (see About MCI, following section). Some people had MCI when they were first seen. Others developed the condition later, so their problems were discovered during follow-up exams. The doctors knew from earlier studies that many people with MCI go on to develop dementia after a few years. But other people show little change over this time, while still others seem to recover or “revert” to cognitively normal when next examined. The doctors found that almost 40% of people with MCI “reverted” in this last way (a typical result). They wanted to know whether these “reverters” differed from other cognitively normal people in their risk of dementia. Over about 5 years of observation, they found that 65% of the “reverters” did go on to develop dementia. That was about 6 times the percentage of other cognitively normal people.

WHAT SETS THESE FINDINGS APART FROM EARLIER WORK?

There aren't many reliable studies of what happens to people who “revert” from MCI to normality. Common sense suggests that these people must be different from others who are normal. We haven't been sure, though, just how different they are. This article offers important new information to answer that question. The study is especially valuable because its subjects came from a population. They weren't necessarily people who got treatment in a clinic or doctor's office. Data from clinic samples suggest what will happen over time to people who have sought medical attention for MCI. But they say little about what happens to the others (sometimes a majority) who haven't sought help. By contrast, this study describes “real” outcomes of people with MCI in a population.

Another strength of this study is that the researchers looked at medical records of people who didn't come back for their next scheduled exam. Here, the researchers had the advantage that people in Olmstead County get almost all their medical care from the Mayo Clinic. We know from other work that people who don't return for follow-up exams have more dementia than others.2 So not tracking people who don't return could lead to underestimates in the rate of onset of dementia. The Mayo Clinic records told Dr. Roberts and colleagues much of what they needed to know about these people.

WHY ARE THE FINDINGS IMPORTANT?

Today, people routinely live into their 70s, 80s, or even 90s. At those ages, problems with memory and other cognitive abilities are so common they are often considered “normal for age.” Unfortunately, many of these people go on to develop dementia. Between “benign” memory problems and dementia there are “in-between” conditions that appear to be the first signs of what may become dementia. This means that many people with MCI are actually in transition to dementia. But other people may have MCI caused by different underlying illnesses. If people with MCI have different underlying illnesses, we may want to treat them differently. We would want to know especially which people do progress to dementia but instead appear normal at their next exam. As Dr. Roberts and colleagues found, this outcome of MCI is quite common. In their study, it happened about 40% of the time. When doctors see this, a natural reaction is to think that they were “fooled” earlier into thinking the person had a serious illness. But this new article suggests they weren't fooled. Instead, they observed that cognition can be variable. This should surprise no one. All people, including those with MCI, have good days and bad days. What this article shows is that people with MCI also experience this sort of fluctuation. So it seems that those who “revert” to normal are often more like people whose MCI progresses to dementia than they are like people who didn't have cognitive problems in the first place.

  • © 2014 American Academy of Neurology

REFERENCES

  1. 1.↵
    1. Roberts RO,
    2. Knopman DS,
    3. Mielke MM,
    4. et al
    . Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology 2014;82:317–325.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Norton M,
    2. Breitner JC,
    3. Welsh KA,
    4. Wyse BC
    . Characteristics of nonresponders in a community survey of the elderly. J Am Geriatr Soc 1994;42:1252–1256.
    OpenUrlPubMed

About mild cognitive impairment

MCI means “mild cognitive impairment.” People with MCI have cognitive problems that aren't as severe as those of dementia. Their main problem area is often with memory. But there may also be problems with finding words, and people may sometimes lose their sense of direction or where they are. When older people have very mild problems like these, doctors often reassure them that such things are “normal for age.” But when the problems are more frequent or severe, they may cause concern. Especially if standard cognitive tests also reveal weaknesses that cause the problems, we may say that a person has MCI. The greatest worry is that MCI may be the “first sign” of more serious difficulties, including Alzheimer dementia. That worry has grown as recent studies have shown that people with MCI often develop dementia over the next few years.

Today we understand that Alzheimer dementia appears only after a decade or more of brain degeneration (preclinical Alzheimer disease). So we worry that people with MCI may have brain degeneration that can be quite advanced. In fact, several careful studies have shown that the brains of people with MCI can have all the changes found in Alzheimer dementia.1,2 And yet follow-up studies of people with MCI often show that they are no worse after a year or 2. Some people may even seem to do better.

These findings can seem puzzling at first but they probably happen for 2 fairly simple reasons. First, we need to remember that MCI can be caused by many health problems other than neurodegenerative diseases. These other problems don't usually end up causing dementia. Second, we are learning that many factors affect the severity of symptoms that result from neurodegeneration. Some of these factors can be biological, like physical health or nutrition, but others like emotional distress or mood are more puzzling. We still have much to learn about the links between neurodegenerative change and cognitive illness, including not only dementia but also MCI.

FOR MORE INFORMATION

AAN Patients and Caregivers site

http://patients.aan.com/go/home

National Institute of Mental Health (NIMH)

http://www.nimh.nih.gov

Alzheimer's Association

http://www.alz.org

National Family Caregivers Association

http://www.thefamilycaregiver.org

REFERENCES

  1. 1.↵
    1. Stephan BC,
    2. Hunter S,
    3. Harris D,
    4. et al
    . The neuropathological profile of mild cognitive impairment (MCI): a systematic review. Mol Psychiatry 2012;17:1056–1076.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Schneider JA,
    2. Arvanitakis Z,
    3. Leurgans SE,
    4. Bennett DA
    . The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol 2009;66:200–208.
    OpenUrlCrossRefPubMed
View Abstract

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • WHAT WERE THE MAIN FINDINGS?
    • WHAT SETS THESE FINDINGS APART FROM EARLIER WORK?
    • WHY ARE THE FINDINGS IMPORTANT?
    • REFERENCES
    • FOR MORE INFORMATION
    • REFERENCES
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

  • All Cognitive Disorders/Dementia
  • Cognitive aging
  • Assessment of cognitive disorders/dementia
  • MCI (mild cognitive impairment)

Alert Me

  • Alert me when eletters are published
Neurology: 96 (9)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise